GlaxoSmithKline Pharmaceuticals Limited Receives GST Order for FY 2021-22

GlaxoSmithKline Pharmaceuticals Limited has received an order dated 30th December 2025 from the Karnataka State GST authorities concerning the financial year 2021-22. The order, issued by the Deputy ...

GlaxoSmithKline Pharmaceuticals Limited has received an order dated 30th December 2025 from the Karnataka State GST authorities concerning the financial year 2021-22. The order, issued by the Deputy Commissioner of Commercial Taxes (Audit) -2.1, DGSTO -2, Bangalore, pertains to the GST rate applied for certain products. The total demand raised amounts to ₹8,56,90,938, comprising ₹4,85,42,948 in tax, ₹3,22,93,695 in interest, and ₹48,54,295 in penalty. The company stated that this order has no impact on its financial operations. GlaxoSmithKline Pharmaceuticals Limited is currently evaluating the demand order and will take appropriate actions in due course. The company received this communication on 30th December 2025.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is GlaxoSmithKline Pharmaceuticals Limited in the news today?

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is in the news due to the announcement is neutral as it reports a gst demand order, but the company has stated there is no impact on its financial operations and it is evaluating the situation.

Other Regulatory FilingsTaxationRegulatory Impact
GlaxoSmithKline Pharmaceuticals LimitedGLAXOhttps://prysm.fi/v2/analyze/GLAXO

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

GlaxoSmithKline Pharmaceuticals Limited Receives GST Order for FY 2021-22

December 31, 2025, 02:09 PM

AI Sentiment Analysis

Top Queries to Ask About GlaxoSmithKline Pharmaceuticals Limited

More Details on This News

GlaxoSmithKline Pharmaceuticals Limited has received an order dated 30th December 2025 from the Karnataka State GST authorities concerning the financial year 2021-22.

The order, issued by the Deputy Commissioner of Commercial Taxes (Audit) -2.1, DGSTO -2, Bangalore, pertains to the GST rate applied for certain products. The total demand raised amounts to ₹8,56,90,938, comprising ₹4,85,42,948 in tax, ₹3,22,93,695 in interest, and ₹48,54,295 in penalty.

The company stated that this order has no impact on its financial operations. GlaxoSmithKline Pharmaceuticals Limited is currently evaluating the demand order and will take appropriate actions in due course. The company received this communication on 30th December 2025.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on GlaxoSmithKline Pharmaceuticals Limited

Discover more trending news on Prysm

View All